Coherus Biosciences
Coherus Biosciences develops, manufactures and commercializes biologic therapeutics for oncology and inflammatory diseases. Learn more
Launch date
Employees
Market cap
AUD230m
Enterprise valuation
AUD400m (Public information from Sep 2024)
Share price
$1.13 CHRS
Redwood City California (HQ)
Authorizing premium user...